J9362 – Injection, trabectedin, 0.01 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9362
- Long description
- Injection, trabectedin, 0.01 mg
- Short description
- Inj, trabectedin, 0.01 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2026
- Last change
- October 1, 2026 – Added
Frequently asked questions
What is HCPCS code J9362?
J9362 is a HCPCS Level II code for injection, trabectedin, 0.01 mg.
Does Medicare cover J9362?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9354 – Injection, ado-trastuzumab emtansine, 1 mg
- J9355 – Injection, trastuzumab, excludes biosimilar, 10 mg
- J9356 – Injection, trastuzumab, 10 mg and hyaluronidase-oysk
- J9357 – Injection, valrubicin, intravesical, 200 mg
- J9358 – Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
- J9359 – Injection, loncastuximab tesirine-lpyl, 0.075 mg
- J9360 – Injection, vinblastine sulfate, 1 mg
- J9361 – Injection, efbemalenograstim alfa-vuxw, 0.5 mg
- J9370 – Vincristine sulfate, 1 mg
- J9371 – Injection, vincristine sulfate liposome, 1 mg
- J9376 – Injection, pozelimab-bbfg, 1 mg
- J9380 – Injection, teclistamab-cqyv, 0.5 mg
- J9381 – Injection, teplizumab-mzwv, 5 mcg
- J9382 – Injection, zenocutuzumab-zbco, 1 mg
- J9390 – Injection, vinorelbine tartrate, 10 mg
- J9393 – Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.